Wiadomości Eulerpool Compass Therapeutics

Eulerpool-AFX Compass Therapeutics

Compass Therapeutics Wiadomości o akcjach

Compass Therapeutics jest obserwowany przez wielu dziennikarzy i inwestorów na całym świecie. Najnowsze wiadomości Compass Therapeutics przedstawiamy tutaj.

• 3 czerwca ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Compass Therapeutics (CMPX) and Kymera Therapeutics (KYMR)
• 30 maja ·

  Yahoo
  Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
• 28 maja ·

  Yahoo
  Compass Therapeutics Announces CEO Transition
• 28 maja ·

  TipRanks
  Compass Therapeutics Announces CEO Transition and New Leadership
• 28 maja ·

  Seeking Alpha
  Compass Therapeutics names Thomas Schuetz as CEO
• 28 maja ·

  Thefly.com
  Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
• 23 maja ·

  Yahoo
  Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
• 16 maja ·

  TipRanks
  Compass Therapeutics: A Buy Rating on Promising Pipeline and Solid Financials
• 14 maja ·

  Yahoo
  Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
• 14 maja ·

  TipRanks
  Buy Rating Affirmed for Compass Therapeutics on Strong Financials and Promising Clinical Trials